Allergan Eye Care

As a leader in eye care for over 70 years, Allergan, an AbbVie company, has discovered, developed, and delivered innovative therapeutic products. We have launched over 125 eye care products and invested billions of dollars in new treatments for the most prevalent eye conditions including glaucoma, ocular surface disease, and retinal diseases such as diabetic macular edema and retinal vein occlusion. With a steadfast dedication to eye care, our team provides support for continuing education programs, eye care teaching institutions, educational initiatives for recent graduates, practice management programs, and a dedicated sales force. For more information visit www.allerganeyecare.com. In May 2020, Allergan became part of AbbVie. AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. The company strives to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health, and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit www.abbvie.com.